$NAOV
NanoVibronix, Inc.

2017 Q2 Form 10-Q Financial Statement

#000114420417027429 Filed on May 15, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q4
Revenue $50.00K $52.00K $50.00K
YoY Change -19.35% -8.77% 25.0%
Cost Of Revenue $20.00K $16.00K $10.00K
YoY Change -9.09% -40.74% 0.0%
Gross Profit $30.00K $36.00K $40.00K
YoY Change -25.0% 20.0% 33.33%
Gross Profit Margin 60.0% 69.23% 80.0%
Selling, General & Admin $530.0K $690.0K $740.0K
YoY Change 64.09% 76.92% 94.74%
% of Gross Profit 1766.67% 1916.67% 1850.0%
Research & Development $160.0K $150.0K $140.0K
YoY Change -7.51% 31.58% 40.0%
% of Gross Profit 533.33% 416.67% 350.0%
Depreciation & Amortization $10.00K $1.000K $0.00
YoY Change -50.0%
% of Gross Profit 33.33% 2.78% 0.0%
Operating Expenses $690.0K $838.0K $880.0K
YoY Change 39.11% 635.09% 79.59%
Operating Profit -$660.0K -$802.0K -$840.0K
YoY Change 44.74% 854.76% 82.61%
Interest Expense -$180.0K -$60.00K -$190.0K
YoY Change 28.57% 500.0% -40.63%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$840.0K -$866.0K -$1.030M
YoY Change 40.0% 76.73% 32.05%
Income Tax $10.00K $11.00K $90.00K
% Of Pretax Income
Net Earnings -$850.0K -$877.0K -$1.120M
YoY Change 39.34% 77.17% 43.59%
Net Earnings / Revenue -1700.0% -1686.54% -2240.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$185.6K -$192.1K -$244.5K
COMMON SHARES
Basic Shares Outstanding 2.633M shares 2.633M shares 2.633M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $220.0K $50.00K $110.0K
YoY Change -72.5% -96.09% -93.17%
Cash & Equivalents $220.0K $50.00K $106.0K
Short-Term Investments
Other Short-Term Assets $50.00K $40.00K $40.00K
YoY Change -58.33% -20.0% -55.56%
Inventory $80.00K $60.00K $67.00K
Prepaid Expenses $34.00K
Receivables $0.00 $0.00 $6.000K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $350.0K $160.0K $221.0K
YoY Change -64.65% -88.73% -87.56%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $10.00K $11.00K
YoY Change 0.0% -50.0% 10.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $400.0K $280.0K $260.0K
YoY Change 66.67% 27.27% 30.0%
Total Long-Term Assets $410.0K $287.0K $273.0K
YoY Change 65.99% 24.24% 31.88%
TOTAL ASSETS
Total Short-Term Assets $350.0K $160.0K $221.0K
Total Long-Term Assets $410.0K $287.0K $273.0K
Total Assets $760.0K $450.0K $494.0K
YoY Change -38.56% -72.74% -75.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $220.0K $123.0K $82.00K
YoY Change 685.71% 186.05% 41.38%
Accrued Expenses $99.00K
YoY Change 110.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $750.0K $631.0K $565.0K
YoY Change 136.59% 91.79% 90.24%
LONG-TERM LIABILITIES
Long-Term Debt $710.0K $130.0K $0.00
YoY Change
Other Long-Term Liabilities $2.340M $2.480M $2.430M
YoY Change 12.5% 28.5% 27.89%
Total Long-Term Liabilities $3.050M $2.618M $2.428M
YoY Change 46.63% 35.79% 28.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $750.0K $631.0K $565.0K
Total Long-Term Liabilities $3.050M $2.618M $2.428M
Total Liabilities $3.810M $3.249M $2.993M
YoY Change 58.95% 43.95% 36.54%
SHAREHOLDERS EQUITY
Retained Earnings -$24.29M -$22.58M
YoY Change -220954.55% 14.4%
Common Stock $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.050M -$2.803M -$2.499M
YoY Change
Total Liabilities & Shareholders Equity $760.0K $450.0K $494.0K
YoY Change -38.56% -72.74% -75.09%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q4
OPERATING ACTIVITIES
Net Income -$850.0K -$877.0K -$1.120M
YoY Change 39.34% 77.17% 43.59%
Depreciation, Depletion And Amortization $10.00K $1.000K $0.00
YoY Change -50.0%
Cash From Operating Activities -$510.0K -$410.0K -$420.0K
YoY Change 6.25% 13.89% 10.53%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 680.0K 350.0K 0.000
YoY Change 1066.67%
NET CHANGE
Cash From Operating Activities -510.0K -410.0K -420.0K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 680.0K 350.0K 0.000
Net Change In Cash 170.0K -60.00K -420.0K
YoY Change -135.42% -82.35% 10.53%
FREE CASH FLOW
Cash From Operating Activities -$510.0K -$410.0K -$420.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$510.0K -$410.0K -$420.0K
YoY Change 6.25% 11.72% 10.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 us-gaap Gross Profit
GrossProfit
30000 USD
CY2017Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
5000 USD
CY2016Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
5000 USD
CY2017Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
287000 USD
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
273000 USD
CY2017Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
370000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
349000 USD
CY2017Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2618000 USD
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
123000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
82000 USD
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24294000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22576000 USD
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
-2803000 USD
CY2017Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2114000 USD
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2079000 USD
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
631000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-2499000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
494000 USD
CY2017Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
21487000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2016Q1 us-gaap Revenues
Revenues
57000 USD
CY2017Q1 us-gaap Revenues
Revenues
52000 USD
CY2016Q1 us-gaap Cost Of Revenue
CostOfRevenue
27000 USD
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
16000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
36000 USD
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
114000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
150000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-866000 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-495000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-877000 USD
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
94000 USD
CY2016Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-495000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1718000 USD
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
838000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-802000 USD
CY2017Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
64000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
245000 USD
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4583971 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4572452 shares
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2831000 USD
CY2017Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-877000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
49000 USD
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
351000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
459000 USD
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-209000 USD
CY2017Q1 us-gaap Depreciation
Depreciation
1000 USD
CY2017Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
35000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6000 USD
CY2016Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5000 USD
CY2017Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7000 USD
CY2016Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
12000 USD
CY2016Q1 us-gaap Depreciation
Depreciation
2000 USD
CY2016Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
0 USD
CY2017Q1 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
-5000 USD
CY2016Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2000 USD
CY2016Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-32000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2000 USD
CY2017Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6000 USD
CY2016Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
CY2017Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2000 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-362000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-405000 USD
CY2016Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
42000 USD
CY2016Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
47000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1614000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1278000 USD
CY2017Q1 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
23000 USD
CY2016Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2016Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
33000 USD
CY2017Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
33000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
350000 USD
CY2016Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2016Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-336000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-55000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
350000 USD
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
351000 USD
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
65000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
9000 USD
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9000 USD
CY2017Q1 nvbxu Contingent Obligation To Royalty
ContingentObligationToRoyalty
492000 USD
CY2017Q1 dei Document Type
DocumentType
10-Q
CY2017Q1 dei Amendment Flag
AmendmentFlag
false
CY2017Q1 dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
CY2017Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2017Q1 dei Entity Registrant Name
EntityRegistrantName
NanoVibronix, Inc.
CY2017Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001326706
CY2017Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Trading Symbol
TradingSymbol
NVBXU
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2632710 shares
CY2016Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 USD
CY2017Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
134000 USD
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
24000000 shares
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2632710 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2632710 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2632710 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2632710 shares
nvbxu Proceeds From Issuance Of Warrants And Notes
ProceedsFromIssuanceOfWarrantsAndNotes
100000 USD
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
37594 shares
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.66
CY2017Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.06 pure
CY2017Q1 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
at a price per share equal to the lesser of: (a) 80% of the price per share at which such securities are sold in such Qualified Financing and (b) $5.90 per share, as such amount may be adjusted for any stock split, stock dividend, reclassification or similar events affecting the Companys capital stock.
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
630000 USD
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
434000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1064000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1039000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2103000 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2884000 USD
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
495000 USD
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
741670 shares
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4227688 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2487301 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4562589 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3189236 shares
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3536348 shares
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.43
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2016Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2017Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
841000 USD
CY2017Q1 us-gaap Dividends
Dividends
0 USD
CY2017Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
222000 USD
CY2017Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
140000 shares
CY2017Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
5.90
nvbxu Proceeds From Issuance Of Warrants And Notes
ProceedsFromIssuanceOfWarrantsAndNotes
100000 USD

Files In Submission

Name View Source Status
0001144204-17-027429-index-headers.html Edgar Link pending
0001144204-17-027429-index.html Edgar Link pending
0001144204-17-027429.txt Edgar Link pending
0001144204-17-027429-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nvbxu-20170331.xml Edgar Link completed
nvbxu-20170331.xsd Edgar Link pending
nvbxu-20170331_cal.xml Edgar Link unprocessable
nvbxu-20170331_def.xml Edgar Link unprocessable
nvbxu-20170331_lab.xml Edgar Link unprocessable
nvbxu-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v466733_10q.htm Edgar Link pending
v466733_ex31-1.htm Edgar Link pending
v466733_ex31-2.htm Edgar Link pending
v466733_ex32-1.htm Edgar Link pending
v466733_ex32-2.htm Edgar Link pending